These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22878814)

  • 41. Orodispersible tablets containing taste-masked solid lipid pellets with metformin hydrochloride: Influence of process parameters on tablet properties.
    Petrovick GF; Kleinebudde P; Breitkreutz J
    Eur J Pharm Biopharm; 2018 Jan; 122():137-145. PubMed ID: 29106946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Testing the disintegration and texture-related palatability predictions for orodispersible tablets using an instrumental tool coupled with multivariate analysis: Focus on process variables and analysis settings.
    Iovanov R; Cornilă A; Bogdan C; Hales D; Tomuță I; Achim M; Tăut A; Iman N; Casian T; Iurian S
    Eur J Pharm Sci; 2024 Jul; 198():106801. PubMed ID: 38754594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does the performance of wet granulation and tablet hardness affect the drug dissolution profile of carvedilol in matrix tablets?
    Košir D; Ojsteršek T; Vrečer F
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1543-1550. PubMed ID: 29848075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet.
    Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G
    Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tablet characteristics and pharmacokinetics of orally disintegrating tablets containing coenzyme Q10 granules prepared by different methods.
    Kashiwagura Y; Takusagawa S; Ikematsu Y; Tanaka S; Namiki N; Uchida S
    Acta Pharm; 2023 Mar; 73(1):107-119. PubMed ID: 36692467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delta-mannitol to enable continuous twin-screw granulation of a highly dosed, poorly compactable formulation.
    Vanhoorne V; Almey R; De Beer T; Vervaet C
    Int J Pharm; 2020 Jun; 583():119374. PubMed ID: 32339631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dextrose monohydrate as a non-animal sourced alternative diluent in high shear wet granulation tablet formulations.
    Mitra B; Wolfe C; Wu SJ
    Drug Dev Ind Pharm; 2018 May; 44(5):817-828. PubMed ID: 29300107
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of a multiparticulate drug delivery system for in situ amorphisation.
    Holm TP; Kokott M; Knopp MM; Boyd BJ; Berthelsen R; Quodbach J; Löbmann K
    Eur J Pharm Biopharm; 2022 Nov; 180():170-180. PubMed ID: 36191869
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Challenges and emerging solutions in the development of compressed orally disintegrating tablets.
    Al-Khattawi A; Mohammed AR
    Expert Opin Drug Discov; 2014 Oct; 9(10):1109-20. PubMed ID: 25045997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dependence of Friability on Tablet Mechanical Properties and a Predictive Approach for Binary Mixtures.
    Paul S; Sun CC
    Pharm Res; 2017 Dec; 34(12):2901-2909. PubMed ID: 28983779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Formulation studies for mirtazapine orally disintegrating tablets.
    Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
    Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stability and repeatability of a continuous twin screw granulation and drying system.
    Vercruysse J; Delaet U; Van Assche I; Cappuyns P; Arata F; Caporicci G; De Beer T; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1031-8. PubMed ID: 23702273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tableting performance of various mannitol and lactose grades assessed by compaction simulation and chemometrical analysis.
    Paul S; Tajarobi P; Boissier C; Sun CC
    Int J Pharm; 2019 Jul; 566():24-31. PubMed ID: 31095984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation and evaluation of orally disintegrating tablets containing vitamin E as a model fat-soluble drug.
    Ikematsu Y; Uchida S; Namiki N
    Chem Pharm Bull (Tokyo); 2015; 63(3):156-63. PubMed ID: 25757486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Controlled-Release Fine Particles Prepared by Melt Adsorption for Orally Disintegrating Tablets.
    Shiino K; Oshima T; Sonoda R; Kimura SI; Itai S; Iwao Y
    Chem Pharm Bull (Tokyo); 2019; 67(10):1152-1159. PubMed ID: 31582635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Computer-aided optimization of carbidopa/levodopa orally disintegrating tablets.
    Qin F; Wan C; Zhang Y
    Drug Dev Ind Pharm; 2024 Apr; 50(4):331-340. PubMed ID: 38456721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.
    Lou H; Liu M; Qu W; Hu Z; Brunson E; Johnson J; Almoazen H
    Drug Dev Ind Pharm; 2014 Jul; 40(7):910-8. PubMed ID: 23621768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced dissolution of sildenafil citrate as dry foam tablets.
    Sawatdee S; Atipairin A; Sae Yoon A; Srichana T; Changsan N
    Pharm Dev Technol; 2019 Jan; 24(1):1-11. PubMed ID: 28135896
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microwave-Assisted Development of Orally Disintegrating Tablets by Direct Compression.
    Kande KV; Kotak DJ; Degani MS; Kirsanov D; Legin A; Devarajan PV
    AAPS PharmSciTech; 2017 Aug; 18(6):2055-2066. PubMed ID: 27995465
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pragmatic approach for engineering porous mannitol and mechanistic evaluation of particle performance.
    Al-Khattawi A; Koner J; Rue P; Kirby D; Perrie Y; Rajabi-Siahboomi A; Mohammed AR
    Eur J Pharm Biopharm; 2015 Aug; 94():1-10. PubMed ID: 25960332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.